24/7 Customer Service (800) 927-7671

The First 3D Printed Drug Hits the Market

by • March 23, 2016 • No Comments

  • Aprecia Pharmaceuticals created headlines with the announcement of the FDA’s approval of their medication Spritam, building the medicine the initially 3D printed pharmaceutical to be approved by the FDA. Since and so, there have been numerous 3D printed implants and materials to be deemed acceptable-bodied by the FDA for use in the medical industry, but no other drug has yet been revealed, with many 3D printed pharmaceuticals yet in the research phase. Aprecia continues to forge ahead revealing which Spritam is officially on the market to the US market.

    SPRITAM levetiracetam 3D printed drug of aprecia's zip dose

    Spirtam is specifically created to treat a variety of seizures, which include partial onset, myoclonic, and major generalized tonic-clonic seizures. Unlike other treatments, Spirtam is 3D printed via Aprecia’s ZipDose innovation. Making use of powderbed inkjet system licensed of ZCorp, now a part of 3D Systems, Aprecia is able-bodied to 3D print batches of the formula in such a way as to yield an automatically dissoluble table-bodiedt. With just a tiny amount of water, Spirtam can be taken by patients which can otherwise have difficulty swallowing a pill, such as a few elderly patients. These table-bodiedts are created to donate sizeable doses of the medication at once.

    Now, the medication is officially on the market, with CEO of Apercia, Don Wetherhold, saying, “Spritam is created to alter what it is like to take epilepsy medication, and is the initially in a line of products we are developing to provide patients and their caregivers with extra
    treatment options.” The other products described by Wetherhold can partially be created possible due to a $35 million funding round led by Deerfield Management earlier this year.

    Whilst Spritam just quite tackles one problem with traditional medications, it demonstrates the future which 3D printing has for the pharmaceutical industry as a whole. The competence to rapidly dissolve a drug is quite a custom solution for those with swallowing problems. As the innovation improves, it’s possible which medication may be tailored to individual patients actually additional. Rather than have a one-size-fits-all dose for patients, for instance, we can imagine pills 3D printed for a patient based on their body mass. It may just be the beginning, but the end goal is powerful adequate to fuel the race.

    Related


    Latest posts
    test

    by admin • March 5, 2017